Walid N. Hanna
Venture investor, PE Healthcare Advisor, Board Member, 25 years of Medtech experience
Professional background
- Executive Chairman and Founder, Perseus Biomics (since 2019…): Ultra fast microbiome mapping technology platform
- President and Founder of Medvent Group (since 2008—), managing a portfolio of 10 venture investments (Abionic, Mindmaze, HYT…)
- President MindMaze Ventures (Gait Up, Intento, Curapy, Msquare…), Head Of Strategy / Corp Dev. MindMaze Group (since 2016—)
- Former President Cardinal Health International Medical Products: revenues of 500M Usd, 800 employees (2002-2007)
- Former Head Of BD at Medtronic Europe and different Finance leadership roles (1997-2003)
- Ex Procter & Gamble (Brand Management), ex Paribas Affaires internationales (Project Finance/Merchant Banking)
Academic background
MBA Wharton , DESS Paris-Dauphine (212), Master of Law (Paris-Nanterre), IEP Dipl. Paris (Eco.Fin. )
Morten Beck Jørgensen
Managing Director, Novo A/S
Msc in Finance and Accounting & Executive MBA from IMD
Professional background
Morten has his corporate background from Nordea in Copenhagen, Denmark where he worked in Investment Banking for 4 years. After the years in Nordea, Morten moved to Novo Nordisk A/S where he worked in Corporate Treasury for another 3 years.
Morten has for the last 10 years been responsible for building up an EUR 5 billion portfolio of financial assets in Novo A/S, the investment company of the Novo Nordisk Foundation
Academic background
Executive MBA at IMD, Switzerland
Msc. in Finance and Accounting from Aarhus University School of Business
Master program at San Francisco State University